Dongsung to distribute Genex’s Oral-Lyn

Dongsung Pharm says it has entered into an exclusive licensing and distribution agreement with the U.S. Generex biotechnology corporation for the importation, marketing, distribution and sale of Oral-Lyn, Generex's proprietary oral insulin spray product in Korea.

The terms of a $1.5 million deal totaling call for payment of a non-refundable, up-front licensing fee and further payment of an a...